Our results showed that the sensitivity of ALX4 gene in CRC and PL alone was inferior to the other two markers, SEPT9 and SDC2, besides ALX4 had a higher false‐positive rate in NEDs. This evidence concerns the gene SEPTIN9 and colorectal carcinoma.